Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹45 Cr
P/E Ratio
21.58
P/B Ratio
2.62
Industry P/E
25.23
Debt to Equity
1.66
ROE
10.33 %
ROCE
12.69 %
Div. Yield
0 %
Book Value
21.73
EPS
2.64
CFO
₹1.21 Cr
EBITDA
₹19.69 Cr
Net Profit
₹6.64 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Roopa
| -22.16 | 11.28 | -16.22 | -6.73 | 19.16 | 38.34 | 24.39 |
|
BSE Commodities
| 2.07 | 0.31 | 6.97 | 1.99 | 7.78 | 28.73 | -- |
|
BSE Small Cap
| -11.96 | 3.43 | 1.57 | 2.12 | 18.79 | 34.74 | 16.10 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Roopa
| 43.01 | -5.42 | 132.06 | 85.47 | 26.45 | -24.48 | -6.67 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 |
|
BSE Commodities
| 8.14 | 17.51 | 1.22 | 61.53 | 26.07 | -4.62 | -19.21 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 241.33 | 2,769.85 | 23.4 | 20.82 | |
| 84.93 | 3,850.82 | 23.98 | 19.18 | |
| 1,396.50 | 4,312.32 | 20.62 | 9.99 | |
| 1,580.80 | 4,166.33 | 84.39 | 6.42 |
No Review & Analysis are available.
Roopa Industries Limited manufactures, markets, and sells nutraceuticals, bulk drugs, and fine chemicals in India. The company offers glucosamine, a nutraceutical/nutritional supplement that is used for the treatment of arthritis; and triphenyl... phosphine, which have applications in antibiotics, statins, specialty resins/paints, fire retardants, phosphonium salts, phase transfer catalysts, agriculture related products, etc., as well as in organic synthesis. It also provides bromine and bromine compounds, including meta bromo anisole, tetra butyl ammonium bromide, 1-bromo-3-chloropropane, 1-acetoxy ethyl bromide, etc., which are used in chemical and pharmaceutical industries; sildenafil citrate; and losartan potassium. The company also offers its products in the United States, Japan, and the European Union. Roopa Industries Limited was incorporated in 1985 and is based in Hyderabad, India. Read more
Incorporated
1985
Chairman
Tumbalam Gooty Raghavendra
Managing Director
Tumbalam Gooty Raghavendra
Group
TG Venkatesh
Headquarters
Kurnool Dist, Andhra Pradesh
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View Announcements
The total asset value of Roopa Industries Ltd stood at ₹ 77 Cr as on 31-Dec-24
The share price of Roopa Industries Ltd is ₹56.94 (BSE) as of 29-Apr-2025 IST. Roopa Industries Ltd has given a return of 19.16% in the last 3 years.
Roopa Industries Ltd has a market capitalisation of ₹ 45 Cr as on 29-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Roopa Industries Ltd is 2.62 times as on 29-Apr-2025, a 26% discount to its peers’ median range of 3.55 times.
The P/E ratio of Roopa Industries Ltd is 21.58 times as on 29-Apr-2025, a 14% discount to its peers’ median range of 25.23 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Roopa Industries Ltd and enter the required number of quantities and click on buy to purchase the shares of Roopa Industries Ltd.
Roopa Industries Limited manufactures, markets, and sells nutraceuticals, bulk drugs, and fine chemicals in India. The company offers glucosamine, a nutraceutical/nutritional supplement that is used for the treatment of arthritis; and triphenyl phosphine, which have applications in antibiotics, statins, specialty resins/paints, fire retardants, phosphonium salts, phase transfer catalysts, agriculture related products, etc., as well as in organic synthesis. It also provides bromine and bromine compounds, including meta bromo anisole, tetra butyl ammonium bromide, 1-bromo-3-chloropropane, 1-acetoxy ethyl bromide, etc., which are used in chemical and pharmaceutical industries; sildenafil citrate; and losartan potassium. The company also offers its products in the United States, Japan, and the European Union. Roopa Industries Limited was incorporated in 1985 and is based in Hyderabad, India.
The prominent promoters of Roopa Industries Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
Star Niochem Pvt Limited |
18.91%
|
|
Sree Rayalaseema Hi-Strength Hypo Limited |
17.45%
|
|
T G RAGHAVENDRA |
8.34%
|
|
JAYANTHI RAGHU TUMBALAM GOOTY |
2.65%
|
The chairman of the company is Tumbalam Gooty Raghavendra, and the managing director is Tumbalam Gooty Raghavendra.
There is no promoter pledging in Roopa Industries Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
4,396
|
|
|
4,100
|
|
|
3,919
|
|
|
2,768
|
| Roopa Industries Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
13.05
|
|
Operating margin(%)
|
3.31
|
|
Net Margin(%)
|
1.81
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Roopa Industries Ltd was ₹2 Cr.
₹0.54
(
